Department of Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Adv Exp Med Biol. 2019;1141:549-580. doi: 10.1007/978-981-13-7647-4_12.
ATP-binding cassette (ABC) transporters are involved in active pumping of many diverse substrates through the cellular membrane. The transport mediated by these proteins modulates the pharmacokinetics of many drugs and xenobiotics. These transporters are involved in the pathogenesis of several human diseases. The overexpression of certain transporters by cancer cells has been identified as a key factor in the development of resistance to chemotherapeutic agents. In this chapter, the localization of ABC transporters in the human body, their physiological roles, and their roles in the development of multidrug resistance (MDR) are reviewed. Specifically, P-glycoprotein (P-GP), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP/ABCG2) are described in more detail. The potential of ABC transporters as therapeutic targets to overcome MDR and strategies for this purpose are discussed as well as various explanations for the lack of efficacy of ABC drug transporter inhibitors to increase the efficiency of chemotherapy.
三磷酸腺苷结合盒(ABC)转运蛋白参与多种不同底物通过细胞膜的主动泵送。这些蛋白质介导的转运调节许多药物和外源性物质的药代动力学。这些转运蛋白参与多种人类疾病的发病机制。癌细胞中某些转运蛋白的过度表达已被确定为对化疗药物产生耐药性的关键因素。在本章中,回顾了 ABC 转运蛋白在人体中的定位、它们的生理作用以及它们在多药耐药(MDR)发展中的作用。特别详细描述了 P-糖蛋白(P-GP)、多药耐药相关蛋白(MRPs)和乳腺癌耐药蛋白(BCRP/ABCG2)。还讨论了将 ABC 转运蛋白作为治疗靶点来克服 MDR 的潜力以及为此目的的策略,以及 ABC 药物转运蛋白抑制剂增加化疗效率的功效缺乏的各种解释。